首页 | 本学科首页   官方微博 | 高级检索  
     

凋亡抑制蛋白Survivin和Bcl-2在非小细胞肺癌中的表达和意义
引用本文:胡雪君,宋娜,刘云鹏,赵志龙,张林,康健. 凋亡抑制蛋白Survivin和Bcl-2在非小细胞肺癌中的表达和意义[J]. 中国肿瘤临床, 2007, 34(2): 92-95
作者姓名:胡雪君  宋娜  刘云鹏  赵志龙  张林  康健
作者单位:1. 中国医科大学附属第一医院呼吸内科,沈阳市,110001
2. 中国医科大学附属第一医院肿瘤内科,沈阳市,110001
3. 中国医科大学附属第一医院胸外科,沈阳市,110001
摘    要:目的:探讨凋亡抑制蛋白Survivin和Bcl-2表达与非小细胞肺癌(NSCLC)预后之间的关系.方法:将88例NSCLC及5例正常肺组织标本制作成组织芯片,应用免疫组织化学S—P法检测Survivin和Bcl-2的表达.并与临床病理特征及长期生存进行比较分析.结果:Survivin胞浆和胞核阳性表达率分别为94.3%和79.5%,Bcl-2胞浆和胞核阳性表达率分别为54.5%和42.0%.而正常肺组织均为阴性,Survivin胞浆表达与年龄等临床参数无关.而Survivin胞核在吸烟者中表达升高(P=0.002),Bcl-2胞浆表达在男性、吸烟者、鳞癌、淋巴结无转移者中升高(P〈0.01).Bcl-2胞核表达在女性、不吸烟者、腺癌和肿瘤大小为T3和T4者中升高(P〈0.05)Survivin表达与NSCLC病人生存期无关。Bcl-2胞浆表达的病人生存期更长(P=0.005),而Bcl-2胞核表达的病人生存期更短(P=0.012)多因素分析显示Survivin和Bcl-2不是影响NSCLC预后的独立危险因素.结论:Survivin检测可能有助于NSCLC的诊断,Bcl-2胞浆和胞核表达可能具有相反的预后意义.

关 键 词:非小细胞肺癌  预后  组织芯片
文章编号:1000-8179(2007)02-0092-04
收稿时间:2006-11-12
修稿时间:2006-11-12

Prognostic Value of Survivin and Bcl-2 expression in Non-small Cell Lung Cancer: A Tissue Microarray Analysis
Hu Xuejun, Song Na, Liu Yunpeng, et al. Prognostic Value of Survivin and Bcl-2 expression in Non-small Cell Lung Cancer: A Tissue Microarray Analysis[J]. Chinese Journal of Clinical Oncology, 2007, 34(2): 92-95
Authors:Hu Xuejun   Song Na   Liu Yunpeng   et al
Affiliation:Department of Respiratory, First Affiliated hospital of China Medical University, Shenyang
Abstract:Objective:To evaluate the prognostic value of survivin and Bcl-2 in patients with non-small cell lung cancer(NSCLC).Methods:Expression of survivin and Bcl-2 was accessed by immunohistochemical staining on tissue microarray sections,and the results were compared with relevant clinical and pathologic data.Results:Positive rate of cytoplasmic and nuclear survivin in NSCLC was 94.3% and 79.5%,respectively.Positive rate of cytoplasmic and nuclear Bcl-2 in NSCLC was 54.5% and 42.0%,respectively.Neither survivin nor Bcl-2 expression was observed in normal lung tissues.There was no correlation between cytoplasmic survivin expression and clinical characteristics,but nuclear survivin expression was higher in smokers (P=0.002).Cytoplasmic Bcl-2 expression was significantly higher in groups with male,smokers,squamous cell carcinoma and no lymph node involvement (P<0.01),and nuclear Bcl-2 expression was significantly higher in groups with male,non-smokers,adenocarcinoma and tumor size with T3 and T4 (P<0.05).However,survivin expression was not related with survival.Patients with positive expression of nuclear Bcl-2 had worse overall survival (P=0.012),whereas positive expression of cytoplasmic Bcl-2 predicted better overall survival (P=0.005).Multivariate analysis using Cox regression modal showed that neither survivin nor Bcl-2 was the important independent prognostic factor for survival.Conclusions:These results indicate that survivin highly expresses in NSCLC,so the ubiquitous expression makes it a potential noval parameter for diagnosis,and cytoplasmic and nuclear expression of Bcl-2 might possess completely opposite prognostic significance in patients with NSCLC.
Keywords:Survivin  Bcl-2
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号